Literature DB >> 4037064

Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth.

G A Homandberg, J E Williams, D Grant, B Schumacher, R Eisenstein.   

Abstract

Two heparin-binding proteolytic fragments of fibronectin--an amino-terminal 29-kd segment and a carboxyl-terminal 40-kd segment-are apparently specific, potent inhibitors of the growth of cultured bovine aortic endothelial cells and inhibit growth in a reversible, dose-dependent manner. In contrast, native fibronectin at higher dosages neither inhibits nor interferes with the effects of the 29-kd fragment. The data, therefore, suggest that fibronectin fragments may participate in the regulation of vascular growth.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4037064      PMCID: PMC1887989     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Selection and characterization of bovine aortic endothelial cells.

Authors:  S M Schwartz
Journal:  In Vitro       Date:  1978-12

2.  Proteolytically derived fragments of human plasma fibronectin and their localization within the intact molecule.

Authors:  M B Furie; D B Rifkin
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

3.  Fibronectin.

Authors:  D F Mosher
Journal:  Prog Hemost Thromb       Date:  1980

Review 4.  The structure and biologic activities of plasma fibronectin.

Authors:  M W Mosesson; D L Amrani
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

5.  Location of a gelatin-binding region of human plasma fibronectin.

Authors:  M B Furie; A B Frey; D B Rifkin
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

6.  Growth regulators in connective tissues. II. Evidence for the presence of several growth inhibitors in aortic extracts.

Authors:  R Eisenstein; E Harper; K E Kuettner; B Schumacher; B Matijevitch
Journal:  Paroi Arterielle       Date:  1979-10

7.  Isolation of a collagen-binding fragment from fibronectin and cold-insoluble globulin.

Authors:  G Balian; E M Click; E Crouch; J M Davidson; P Bornstein
Journal:  J Biol Chem       Date:  1979-03-10       Impact factor: 5.157

8.  Preparation of functionally intact monomers by limited disulfide reduction of human plasma fibronectin dimers.

Authors:  G A Homandberg; D L Amrani; D B Evans; C M Kane; E Ankel; M W Mosesson
Journal:  Arch Biochem Biophys       Date:  1985-05-01       Impact factor: 4.013

9.  Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent.

Authors:  D Gospodarowicz; J Moran; D Braun; C Birdwell
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

10.  Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone.

Authors:  J Gross; R G Azizkhan; C Biswas; R R Bruns; D S Hsieh; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  24 in total

Review 1.  Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.

Authors:  G E Davis; K J Bayless; M J Davis; G A Meininger
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  The role of angiogenesis in rheumatoid arthritis: recent developments.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 3.  Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored.

Authors:  Jan Buter; Herbert M Pinedo
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

Review 4.  Therapeutic inhibition of angiogenesis.

Authors:  Hua-Tang Zhang; Roy Bicknell
Journal:  Mol Biotechnol       Date:  2003-10       Impact factor: 2.695

Review 5.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 6.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

7.  Interaction of heparin with fibronectin and isolated fibronectin domains.

Authors:  K C Ingham; S A Brew; D H Atha
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

Review 8.  The preclinical evaluation of angiogenesis inhibitors.

Authors:  M S O'Reilly
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 9.  Citrate chemistry and biology for biomaterials design.

Authors:  Chuying Ma; Ethan Gerhard; Di Lu; Jian Yang
Journal:  Biomaterials       Date:  2018-05-04       Impact factor: 12.479

10.  Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis.

Authors:  Birgit Mosch; Bettina Reissenweber; Christin Neuber; Jens Pietzsch
Journal:  J Oncol       Date:  2010-03-10       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.